Brief: New York Blood Center Enterprises Acquires Commercial-Scale Cell & Gene Therapy Development And Manufacturing Facilities From Talaris Therapeutics
04/10/2023 13:46
Oct 4 (Reuters) - Talaris Therapeutics Inc TALS.O :
* NEW YORK BLOOD CENTER ENTERPRISES ACQUIRES
COMMERCIAL-SCALE CELL
& GENE THERAPY DEVELOPMENT AND MANUFACTURING FACILITIES FROM
TALARIS THERAPEUTICS
Source text for Eikon: ID:nGNX8JRZDK
Further company coverage: TALS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tourmaline Bio
See all newsBrief: Novartis Completes Acquisition Of Tourmaline Bio
Brief: Novartis Announces Expiration Of Tourmaline Bio Tender Offer
Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports (updated)
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Tourmaline Bio
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy